Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)

SHE:300009 Revenue

Anhui Anke Biotechnology (Group) had revenue of 541.72M CNY in the quarter ending March 31, 2026, a decrease of -13.84%. This brings the company's revenue in the last twelve months to 2.56B, up 2.02% year-over-year. In the year 2025, Anhui Anke Biotechnology (Group) had annual revenue of 2.65B with 4.36% growth.

• Revenue (ttm): 2.56B
• Revenue Growth: +2.02%
• P/S Ratio: 5.84
• Revenue / Employee: 1.02M
• Employees: 2,505
• Market Cap: 14.95B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.65B	110.48M	4.36%
Dec 31, 2024	2.54B	-329.71M	-11.51%
Dec 31, 2023	2.87B	534.69M	22.94%
Jan 1, 2023	2.33B	162.30M	7.48%
Dec 31, 2021	2.17B	467.35M	27.47%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 18, 2026

Data Sources Report a data error